ORNBV Orion Oyj Class B

Orion Corporation: Acquisition of Own Shares 15.09.2022

Orion Corporation: Acquisition of Own Shares 15.09.2022

Orion Corporation NOTIFICATION

 

15.09.2022 at 18:30

 

ORION CORPORATION: ACQUISITION OF OWN SHARES 15.09.2022

Date15.09.2022 
Exchange transaction Buy 
Share classORNBV 
Amount11,400    
Average price/share45.2360EUR
Highest price/share45.6200EUR
Lowest price/share44.8000EUR
Total price515,690.40   EUR
   

The shares held by Orion Corporation on 15.09.2022:

 ORNBV 682,077 

On behalf of Orion Corporation

 

Skandinaviska Enskilda Banken AB (Publ)

 

Antti Salakka         Janne Tiihonen

 

 

For more information, please contact:

Olli Huotari, SVP, Corporate Functions, Orion Corporation

tel. 4



Attachment



EN
15/09/2022

Underlying

ORNBVOrion Oyj Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Orion Oyj Class B

 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion’s collaborator, MSD, expands clinical development program for op...

Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers ORION CORPORATION INVESTOR NEWS 21 MAY 2025 at 07.30 EEST                    Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers Orion’s collaborator, MSD, has expanded the development program for opevestostat (MK-5684) to now include women’s cancers. A new Phase 2 clinical trial evaluating the safety and efficacy of opevesostat for the treatment of breast, endometrial and ovarian cancers has been posted to ClinicalTrials.gov database. The stu...

7h / 25m 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orionin yhteistyökumppani MSD laajentaa opevesostaatin kliinistä kehit...

Orionin yhteistyökumppani MSD laajentaa opevesostaatin kliinistä kehitysohjelmaa naisten syöpiin ORION OYJ                SIJOITTAJAUUTINEN 21.5.2025 KLO 7.30          Orionin yhteistyökumppani MSD laajentaa opevesostaatin kliinistä kehitysohjelmaa naisten syöpiin Orionin yhteistyökumppani MSD on laajentanut opevesostaatin (MK-5684) kehitysohjelmaa sisältämään nyt myös naisten syöpiä. ClinicalTrials.gov-tietokannassa on julkaistu uusi kliininen Faasi 2 -tutkimus, joka arvioi opevesostaatin turvallisuutta ja tehoa rintasyövän, kohdun endometriumin syövän sekä munasarjasyövän hoidossa. Tutk...

7h / 25m 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS8 May 2025 at 16:30 EEST          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 7 May 2025 below ...

May 8, 2025 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoit...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) ORION OYJ        PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE        8.5.2025 KLO 16.30         Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n mukaisen ilmoituksen, jonka mukaan BlackRock, Inc.:n ja sen rahastojen suoraan, välillisesti ja rahoitusinstrumenttien kautta omistamien Orionin osakkeiden osuus on 7.5.2025 alittanut viisi (5) prosenttia Orion Oyj:n kaikista osakkeista. BlackRock...

May 8, 2025 1 EN
 PRESS RELEASE
Free
ORNBV Orion Oyj Class...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 May 2025 at 17.00 EEST          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 6 May 2025 above ...

May 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch